Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enterprise Therapeutics
Biotech
Roche targets cystic fibrosis with deal for TMEM16A potentiator
The deal, which is worth £75 million upfront to Enterprise’s shareholders, gives Roche a drug designed to treat all cystic fibrosis patients.
Nick Paul Taylor
Oct 7, 2020 8:10am
Ex-Pfizer R&D head Abraham joins Vividion—Chutes & Ladders
Feb 14, 2020 9:30am
Enterprise Therapeutics nabs Novartis VC exec as new CMO
Feb 10, 2020 8:20am
